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Expression of killer cell Ig-like receptors (KIRs) diversifies human natural killer cell 
populations and T cell subpopulations. Whereas the major histocompatibility complex class I 
binding functions of inhibitory KIR are known, specificities for the activating receptors have 
resisted analysis. To understand better activating KIR and their relationship to inhibitory 
KIR, we took the approach of reconstructing their natural history and that of Ly49, the 
analogous system in rodents. A general principle is that inhibitory receptors are ancestral, 
the activating receptors having evolved from them by mutation. This evolutionary process of 
functional switch occurs independently in different species to yield activating KIR and Ly49 
genes with similar signaling domains. Selecting such convergent evolution were the 
signaling adaptors, which are older and more conserved than any KIR or Ly49. After 
functional shift, further activating receptors form through recombination and gene 
duplication. Activating receptors are short lived and evolved recurrently, showing they are 
subject to conflicting selections, consistent with activating KIR’s association with resistance 
to infection, reproductive success, and susceptibility to autoimmunity. Our analysis suggests 
a two-stage model in which activating KIR or Ly49 are initially subject to positive selection 
that rapidly increases their frequency, followed by negative selection that decreases their 
frequency and leads eventually to loss.
 
NK cells are effector lymphocytes of innate im-
munity that respond to infection (1, 2), malig-
nancy (3), and allogeneic hematopoietic trans-
plantation (4); they also facilitate placentation in
reproduction (5). NK cell responses are deter-
mined by batteries of activating and inhibitory
receptors (6). Ligands for several NK cell recep-
tors are MHC class I and structurally related
molecules. The NK cell receptors that recognize
polymorphic MHC class I molecules are them-
selves encoded by diverse, polymorphic, and
rapidly evolving gene families that contribute to
the diversity and repertoire of NK cell popula-
tions and T cell subpopulations (7, 8). Further
emphasizing the evolutionary plasticity and ver-
satility of these NK cell receptors, the analogous
functions are performed by structurally unrelated
glycoproteins in different species, as exemplified
by the killer cell Ig-like receptors (KIR) of pri-
mates and the Ly49 receptors of rodents (9).
In contrast to MHC polymorphism, KIR
polymorphism can affect a receptor’s signal-
ing function as well as its binding to ligands.
Activating  function is effected by a positively
charged residue in the transmembrane region,
whereas inhibitory function is conferred by
inhibitory tyrosine-containing immunomotifs
(ITIM) in the cytoplasmic tail. Of the 14 human
KIR, seven are inhibitory, six are activating,
and one has dual function. The balance between
activating and inhibitory receptors at the NK
cell surface is reflected in the population genetics:
 
KIR 
 
haplotypes divide into two functionally
distinct groups according to their complexity
and the content of genes encoding activating
KIR (10). Group A haplotypes have only one
activating 
 
KIR
 
 gene (
 
KIR2DS4
 
), and it is fre-
quently disabled (11, 12). The more com-
plicated group B haplotypes can have up to
five of the six genes encoding activating re-
ceptors (KIR2DS1–5 and KIR3DS1) as well as
additional genes encoding inhibitory receptors
(KIR2DL5A and KIR2DL5B). Consequently,
human genotypes vary widely in their content
of activating 
 
KIR
 
, as do the frequencies in hu-
man populations (13). These distributions point
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to distinctive and balancing selection for haplotypes that are
rich or poor in activating 
 
KIR
 
.
Certain pairs of KIR have similar extracellular domains
but differ in their signaling function. Inhibitory receptors
specific for HLA-C, KIR2DL1 and KIR2DL2/3, pair with
the activating receptors KIR2DS1 and KIR2DS2, re-
spectively. Likewise, the inhibitory receptor for HLA-B,
KIR3DL1, is paired with the activating receptor KIR3DS1.
Figure 1. The signaling domains of short-tailed hominoid KIR form a 
monophyletic group within lineage III KIR. (A) Comparison of mammalian 
KIR signaling domains shows that primate sequences form a monophyletic 
group. To simplify the tree, the primate sequences were collapsed. (B) Among 
primate KIR the signaling domains of short-tailed KIR form a monophyletic 
group within lineage III (B). Neighbor joining (NJ) and Bayesian trees gave 
statistically similar topologies; the NJ topology is displayed (using a mid-
point rooting). Colored boxes denote the different KIR lineages. The statisti-
cal support for each node (expressed as a percentage) was given by the 
interior branch test confidence probability and the Bayesian posterior prob-
ability. Values are shown for nodes supported by  90% with one or both 
methods; asterisks indicate values  90%. Nodes marked by a filled circle 
were supported  95% by both methods. Gg, Gorilla gorilla; Mm, Macaca 
mulatta; Pt, Pan troglodytes; Pp, Pan paniscus, Popy, Pongo pygmaeus. 
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These relationships suggest how KIR signaling function
might be switched, from activating to inhibitory, or vice
versa, in the course of evolution (14). The ligand-binding
specificities of the inhibitory receptors are well characterized,
but similar studies of the activating receptors have met with
limited success (15–18), although clinical correlations point
to their interaction with HLA class I. For HIV infection, the
combination of KIR3DS1 and certain HLA-B allotypes was
correlated with slower progression to AIDS (19), and certain
combinations of HLA-C with KIR2DS1 and KIR2DS2
correlate with autoimmune conditions (20–22). For infec-
tious disease, the plausibility of such mechanisms is shown by
the demonstration that the activating Ly49H variant pro-
vides specific resistance to cytomegalovirus infection in a
mouse model (23).
Because of the evolutionary plasticity of MHC class I–
specific NK cell receptors and the unprecedented species-
specific differences they exhibit, it becomes important to un-
derstand the general principles by which these receptors—
particularly the activating receptors—evolve. The overall
similarity of activating and inhibitory KIR demonstrates their
common origin but leaves unanswered questions as to which
came first—activating or inhibitory KIR—and how the sig-
naling function is switched. Using phylogenetic analysis and
evolutionary reconstruction, we have examined the natural
history of KIR and can now answer these questions with
confidence. Similar analysis of rodent Ly49 demonstrated that
these evolutionary processes are remarkably parallel.
 
RESULTS
Hominoid-specific evolution of activating KIR
 
Signaling functions are determined by basic residues of the
transmembrane region (TM) that bind to activating adaptor
molecules and of ITIMs in the cytoplasmic tail (CYT). In
this paper, we define the combination of TM and CYT as
the KIR signaling domain. Phylogenetic comparison of the
Figure 2. The STK ancestor evolved by functional switch of an in-
hibitory KIR. The signaling domain sequences of the STK, LTK, and lineage 
III ancestors were reconstructed. The upper panel shows the amino acid 
sequence. Residues common to the different predictions are indicated on 
the main line. For variable residues, the possibilities are indicated above 
and below the main line. The characteristic charged residue of activating 
KIR and the ITIM motifs of inhibitory KIR are boxed. Two models were used 
to perform the ancestral sequence reconstruction. The middle panel shows 
the first model. The tree topology corresponds to that obtained in the 
Bayesian analysis performed in Fig. 1; the relevant part of the tree is dis-
played. The bottom panel shows the second model. This topology repre-
sents a modification of the first topology in which the KIR3DL3 and Popy-
KIR2DLA/B sequences are grouped with the lineage III LTK group. This 
modification is based on the result presented in Fig. 3 A. The trees on the 
left sides of the panels show the nodes corresponding to the recon-
structed sequences. Empty symbols pertain to the marginal reconstruction 
method alone; filled symbols pertain to both the marginal reconstruction 
and Bayesian methods. Positions varying among the predicted sequences 
and corresponding to the variable positions in the upper panel are shown 
in the schemes on the right sides of the panels. The amino acid substitu-
tions leading to the different groups are shown next to the arrows joining 
the groups. Residues that change along each branch are in boldface type. 
Parentheses show positions where marginal reconstruction and Bayesian 
methods gave different results. 
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sequences encoding the signaling domains of mammalian
KIR shows that all primate KIR signaling domains form a
monophyletic group (Fig. 1 A) and thus derive from one
unique common ancestor. Within the primate KIR, the sig-
naling domains of all the activating, short-tailed KIR (STK)
of the hominoids (i.e, KIR2DS and KIR3DS) form a mono-
phyletic group (Fig. 1 B). In contrast, the signaling domains
of the long-tailed KIR (LTK; i.e., KIR2DL and KIR3DL)
segregate into several groups, corresponding chiefly to the
lineages defined from cDNA sequences (24). In the same
phylogenetic tree, the STK all group with the LTK of lin-
eage III, which includes the HLA-C–specific KIR (Fig. 1
B). In summary, the signaling domains of all modern homi-
noid KIR2DS and KIR3DS derive from a unique hominoid
ancestor that was a lineage III KIR.
 
Activating KIR evolved from inhibitory KIR
 
Trees constructed for the primate signaling domain com-
prise two deep clades, one containing 
 
KIR2DL4
 
 and related
 
KIR
 
 (lineage I-A) and the other that divides into related
groups of 
 
KIR
 
 corresponding to the lineage I-B, II, III, IV,
and rhesus monkey 
 
KIR2DL5
 
 and 
 
KIR1D
 
 (Fig. 1 B).
Whereas all these subclades contain inhibitory LTK, only
lineage III also contains activating STK. That the 
 
STK
 
 are
deeply nested within the lineage III 
 
KIR
 
 indicates that the
ancestral lineage III 
 
KIR
 
 was a 
 
LTK
 
 rather than a 
 
STK
 
. The
ancestral STK would then have evolved from a lineage III
LTK with accompanying functional switch. To assess the
validity of this model, we reconstructed the sequences for
the signaling domain of the last common ancestor of the
 
STK
 
, the lineage III 
 
LTK
 
, and of all lineage III 
 
KIR
 
 (Fig. 2).
Because the relative positions of three sequences (
 
KIR3DL3
 
and 
 
Popy-KIR2DLA
 
/
 
B
 
) within the lineage III were uncer-
tain, two alternative trees were used to reconstruct the an-
cestral sequences. For each alternative tree, the results of two
independent methods of analysis indicated that the last com-
mon ancestor of the lineage III KIR was an inhibitory LTK
(Fig. 2).
These reconstructions of ancestral sequence were also
used to predict the amino acid substitutions that formed the
ancestral STK. Two amino acids were identically predicted
by the two analytical methods (Fig. 2). These substitutions
are precisely those that switch the receptor’s function from
inhibition to activation. Activating function was gained by
introduction of a positive charge (K) into the TM, through
which STK interact with the DAP12 adaptor (25, 26). In-
hibitory function was lost by introduction of a stop codon
within the membrane proximal ITIM motif of the CYT.
Because both changes occurred in the same evolutionary
branch, it is not possible to determine which occurred first.
That the evolution of the ancestral STK involved only sub-
stitutions that directly affected signaling function is indicative
of selection.
To assess the impact of natural selection on KIR signal-
ing domains, we estimated their mean number of synony-
mous substitutions per synonymous nucleotide site (d
 
S
 
) and
number of nonsynonymous substitutions per nonsynony-
mous nucleotide site (d
 
N
 
) (Table I). Although seven of the
nine groups analyzed show an excess of synonymous substi-
tutions (d
 
N
 
/d
 
S
 
 
 
 
 
 1), for six groups it did not reach statistical
significance. Such evidence for weak purifying selection can
be attributed to the small size of the signaling domain (63 aa)
and the relatively few residues in the TM and CYT domains
that are functionally critical. Many other positions, however,
are likely to tolerate a range of substitutions, for example hy-
drophobic substitutions in the TM. The KIR group showing
statistically significant purifying selection (P 
 
 
 
 0.05) was the
STK. Because the analysis was performed on present-day
STK sequences, it did not include the functionally important
substitutions that produced the functional shift; rather, it in-
 
Table I.
 
Mean number of synonymous substitutions per synonymous site (d
 
S
 
) and nonsynonymous substitutions per 
nonsynonymous site (d
 
N
 
) substitutions within the different KIR lineages/groups for the TM and CYT (partial) domains
 
d
 
N
 
(*100)
 
a
 
Standard error
(*100)
 
a
 
d
 
S
 
(*100)
 
a
 
Standard error
(*100)
 
a
 
d
 
N
 
/
 
d
 
5
 
Z-value
P
(
 
d
 
N
 
 
 
 
 
 
 
d
 
S
 
)
 
STK
 
3.62 1.02 8.95 2.34 0.40
 
 
 
2.07
 
 
 
0.05
Lineage IA 8.30 1.66 4.96 2.08 1.67 1.20 NS
Lineage IB 0.85 0.59 2.93 1.64 0.29
 
 
 
1.18 NS
Lineage II 3.51 1.02 5.02 1.79 0.70
 
 
 
0.72 NS
Lineage III 
 
LTK
 
(Homo, Pan, Gorilla)
4.79 0.97 5.48 1.73 0.87
 
 
 
0.34 NS
 
Popy
 
-
 
KIR2DL
 
 (A/B)
 
KIR3DL3
 
4.35 1.32 5.23 2.50 0.83
 
 
 
0.30 NS
Lineage III 
 
LTK
 
(Hominoids) 
5.96 1.05 6.44 1.63 0.93
 
 
 
0.24 NS
Lineage IV 3.32 1.04 3.30 1.28 1.00 0.01 NS
 
Mm
 
-
 
KIR2DL5
 
 (0.1/0.2)
 
Mm
 
-
 
KIR1D
 
6.55 1.64 9.70 3.33 0.68
 
 
 
0.94 NS
 
a
 
Values were multiplied by 100 to simplify the presentation. 
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volved only substitutions that occurred after the shift. The
result shows that, in the subsequent evolution and expansion
of the STK family, purifying selection has preserved the
structure of the signaling domain and its activating function.
To date, STK have been characterized only in homi-
noids. To assess the likelihood that other primate species
possess STK, we estimated a time range for occurrence of
the functional switch that gave rise to the STK ancestor (Ta-
ble II). This analysis was performed for the two models
shown in Fig. 2. For both models, the lower limit of the
range, which corresponds to the last common ancestor of all
STK, was estimated at 
 
 
 
13.5
 
 
 
million years ago (MYA). The
upper limit of the range, which corresponds to the last com-
mon ancestor of all lineage III KIR, was estimated at 
 
 
 
18
MYA. The range of 13.5 to 18 MYA indicates that STK
may exist in hylobatids (gibbons and siamangs), because their
divergence from other hominoids is estimated to have oc-
curred 16.5–18.5 MYA (27). On the other hand, STK are
unlikely to be found in Old World monkeys. Although esti-
mates of the Old World monkey–hominoid divergence time
vary, most evidence points toward a minimum of 23 MYA
(28), corresponding to the upper limit of the 95% confi-
dence interval for the upper range of the STK emergence
(Table II).
 
Expansion of the STK occurred mainly by recombination
 
After the formation of the first 
 
STK
 
 gene in a hominoid an-
cestor, a family of hominoid 
 
STK
 
 genes was formed by ex-
pansion, as exemplified by the presence of several 
 
STK
 
 genes
in modern humans, orangutans, and common chimpanzees.
Although duplication of a complete gene is a necessary
mechanism for the expansion of gene families, we previously
showed that recombination between genes has been the
main mechanism generating new 
 
KIR
 
 (24). To investigate
the mechanisms that diversified and expanded the 
 
STK
 
, we
performed a domain-by-domain phylogenetic analysis. Trees
constructed from the signaling domain of the lineage III 
 
KIR
 
revealed four subclades within the 
 
STK
 
 clade. These sub-
clades divide along species-specific lines: human, gorilla, orang-
utan, and the two chimpanzees (Fig. 3 A). Within each spe-
cies or pair of species, the modern 
 
STK
 
 derive from a single
common ancestor. The tight clustering of the 
 
STK
 
 in the
signaling-domain tree does not extend to trees constructed
for the extracellular domains D2 (Fig. 3 B), D1 (Fig. 3 C),
and D0 (Fig. 3 D). Here the 
 
STK
 
 are distributed among var-
ious branches of the lineage III 
 
KIR
 
 and are also found in
other 
 
KIR
 
 lineages (Fig. 3). From domain to domain, the
phylogenetic relationships between the 
 
STK
 
 differ, evidence
for their diversification by recombination.
Three 
 
STK
 
—bonobo 
 
Pp-KIR3DSA
 
, orangutan 
 
Popy-
KIR3DS2
 
, and human 
 
KIR3DS1—
 
have extracellular do-
mains that cluster with lineage II 
 
KIR
 
. Each of these 
 
KIR
 
was formed by an interlineage recombination in which the
Ig domains of a lineage II 
 
KIR
 
 combined with the signaling
domain of an activating lineage III KIR2D. That 
 
Pp-
KIR3DSA
 
, 
 
Popy-KIR3DS2
 
, and 
 
KIR3DS1 are not nearest
neighbors in the signaling domain tree (Fig. 3 A) argues
against their being orthologous KIR and for their formation
by independent recombination events in bonobo, orangu-
tan, and human evolution. That independent acquisition of
an activating KIR3D occurred in each of these species
provides a striking example of parallel (convergent) evolu-
tion. A further product of interlineage recombination is Pt-
KIR3DS2, for which the D0 domain clusters with lineage V
KIR (Fig. 3 D).
For the remaining 10 STK, all the domains are of lineage
III. Reconstruction of their histories is hindered by lack of
resolution in the D2 domain tree (Fig. 3 B) and, to lesser
extent, in the D1 domain tree (Fig. 3 C). The D0 domain
tree (Fig. 3 D) is well resolved and shows that five STK
(Gg-KIR2DSa, KIR2DS3, KIR2DS5, Pt-KIR2DS4, and
KIR2DS4) form a cluster resembling that for the signal-
ing domain (Fig. 3 A). Gg-KIR2DSa, Pt-KIR2DS4, and
KIR2DS4 may represent orthologues, whereas KIR2DS3
and KIR2DS5 are probably products of gene duplication. In
contrast, KIR2DS1 and KIR2DS2 are recombinants, as seen
from their distinctive positions in the trees for the D0 do-
main and the signaling domain. In summary, of the 14 STK,
Table II. Divergence times for the emergence of the activating KIR and Ly49
Group Node Limit Mean (MYA) 95% confidence interval (MYA)
STK, model 1 Root STK lower 13.2   1.8 10.5–17.5
Root lineage III upper 18.2   2.3 14.1–23.2
STK, model 2 Root STK lower 13.6   1.9 10.6–18.0
Root lineage III upper 18.0   2.4 13.7–23.1
Mm-KIR3DH Mm-KIR3DH/
Mm-KIR2DL4
10.3   2.7 5.9–16.2
Activating Ly49 Root activating Ly49 lower 18.5   2.4 14.3–23.2
Root rodent Ly49 upper 31.1   4.2 24.1–40.4
Rat Ly49s3 Ly49s3/Rno (1) lower 3.5   2.1 0.4–8.7
  Ly49s3/Rno (6) upper 15.7   3.1 9.9–22.1EMERGENCE OF ACTIVATING KIR AND LY49 | Abi-Rached and Parham 1324
six are clearly products of recombination, four are possibly
orthologues, and two the products of gene duplication. The
remaining two STK are the orangutan KIR2D, for which
the genomic sequences corresponding to the D0 domains are
not known; they could be products of either gene duplica-
tion or recombination.
Distinctive signaling domain in activating monkey KIR
In hominoids, KIR2DL4 seems to be unique because it is a
LTK with activating function (29–31) and because of its
ubiquitous expression by NK cells. KIR2DL4 is also the
only KIR that is shared by hominoids and Old World mon-
keys, represented in our study by the rhesus macaque. Be-
Figure 3. Expansion of the STK was driven mainly by recombination. 
Phylogenetic trees were constructed for nucleotide sequences corre-
sponding to each domain of the lineage III KIR defined in Fig. 1: (A) TM/CYT–
signaling domain; (B) D2 domain; (C) D1 domain; (D) D0 domain. The KIR 
lineages are labeled on the right side of each panel. Shaded boxes denote 
the STK sequences. NJ, parsimony (Pars), and Bayesian (Bay) methods gave 
trees with statistically similar topology; the NJ trees are shown (using a 
midpoint rooting). The support for each node (expressed as a percentage) 
was given by the NJ and parsimony bootstrap proportion and by the Bayesian 
posterior probability. Values are shown for nodes supported by   50% for 
the bootstrap proportion analyses and by  90% for the posterior proba-
bility analysis. Asterisks indicate values below these cutoffs. For the signal-
ing domain (A) a fourth test, a maximum-likelihood bootstrap analysis, 
was performed; the bootstrap proportion was estimated for each node 
and indicated where   50%. At nodes the support for the four methods 
(NJ, Bayesian, parsimony, and maximum likelihood) are organized as 
shown in the upper left. Species abbreviations are as in Fig. 1. All the 
analyses were performed with a complete deletion dataset (supplemental 
Material and methods). (D) A group of sequences potentially correspond-
ing to the STK group is boxed.JEM VOL. 201, April 18, 2005 1325
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sides the KIR2DL4 orthologue, the rhesus macaque has sev-
eral Mm-KIR3DH (32, 33) for which the signaling domain
resembles that of KIR2DL4 (Fig. 4 A). This similarity does
not extend to the Ig-like domains (Fig. 4, B–D) where the
four Mm-KIR3DH cluster in lineage IV with the other Mm-
KIR3D. The Mm-KIR3DH are activating receptors formed
by recombining the signaling domain of Mm-KIR2DL4
with the extracellular domains of Mm-KIR3D. Unlike
KIR2DL4, they do not express exon 8 (32, 33), which
causes a frame shift that eliminates the two ITIMs of the
Mm-KIR2DL4 tail and leaves Mm-KIR3DH with only ac-
tivating potential. The similarity of the signaling domain in
the four Mm-KIR3DH shows that recombination between
Mm-KIR2DL4 and Mm-KIR3DL occurred only once. We
estimate this event took place  10.5 MYA (Table II), a time
close to the divergence of Cercopithecini (guenons, green
monkeys, and patas monkeys) from Papionini (macaques and
Papionina),  8–9.5 MYA (27), probably after the separa-
tion of colobines (leaf-eating monkeys) and cercopithecines
(cheek-pouched monkeys),  13–14 MYA (27), and before
the macaques diverged from the Papionina (baboons, man-
gabeys, and mandrills),  7–8 MYA (27). We predict, there-
fore, that KIR3DH genes are present in all Papionini and
possibly in all living cercopithecines but not in colobines.
The Ig domain sequences of Mm-KIR3DH, particularly D0
(Fig. 4 D), are not monophyletic, suggesting the existence
of more than one Mm-KIR3DH locus. Because the Mm-
KIR3DH sequences do not cluster tightly in the Ig domain
trees, the different loci probably evolved by recombination
rather than gene duplication.
Activating KIR coopted more ancient signaling pathways
Parallel evolution formed activating NK receptors from in-
hibitory ones in hominoids and Old World monkeys. For
hominoid STK, DAP12 is the signaling adaptor (25, 26),
whereas for rhesus monkey KIR3DH it is probably FCER1G,
which is also the signaling adaptor for KIR2DL4 (34). To de-
termine whether the adaptor molecules evolved before, after,
or at the same time as the activating KIR, we performed
phylogenetic analyses on sequences from various species
that were reported to resemble the signaling adaptors of
human and murine immune receptors. This analysis re-
vealed DAP12, FCER1G, and related DAP10 and CD3Z
are present and well conserved in several orders of mammals,
as well as in amphibians and bony fishes (Fig. 5). These data
strongly support a scheme in which DAP12 and FCER1G
Figure 4. Rhesus monkey activating 3Ig KIR use a modified KIR2DL4 
signaling domain. Phylogenetic trees were constructed for nucleotide 
sequences corresponding to each domain of the lineage I-A and IV KIR 
defined in Fig. 1: (A) TM/CYT signaling domain; (B) D2 domain (the tree 
was rerooted because the midpoint rooting was influenced by the long 
branch of the group containing Mm-KIR3DL9 and Mm-KIR3DL10); (C) D1 
domain; (D) D0 domain. Tree construction, evaluation, and statistical tests 
were as described in the legend of Fig. 3; representative NJ trees are 
shown. Species abbreviations are as in Fig. 1.EMERGENCE OF ACTIVATING KIR AND LY49 | Abi-Rached and Parham 1326
emerged before separation of mammals and bony fishes, more
than 400 MYA. Consequently, when activating KIR were
formed in primates,  13.5–18 MYA for the STK and  10.5
MYA for the rhesus monkey KIR3DH (Table II), they were
able to coopt a preexisting signaling pathway. The implica-
tion is that the constraints imposed by the existing signaling
pathways guided the evolution of the activating KIR by se-
lecting for variants that could coopt such pathways.
Parallel evolution of activating rodent Ly49 and primate KIR
Although rodent genomes contain KIR genes, their properties
and functions seem to be dissimilar to the hominoid KIR gene
family (35). In mice and rats, the functional equivalent of KIR
is Ly49, a structurally divergent family of lectinlike glycopro-
teins that includes both inhibitory and activating receptors (36).
Although Ly49 receptors have their signaling domain (CYT-
TM) at the amino-terminus, compared with the carboxy-ter-
minus for KIR, their activating and inhibitory motifs are
similar. It was therefore intriguing to see how the evolution of
activating Ly49 compared with that of the activating KIR.
Phylogenetic analysis of the signaling domains of mouse
and rat Ly49 family members also included sequences from
other species, including the single, nonfunctional human
Ly49 gene. With two exceptions, all of the activating Ly49
genes form a unique monophyletic group that includes no in-
hibitory Ly49. (The two exceptions are the rat Ly49s3 and
the predicted activating Ly49C of the horse; Fig. 6 A). Thus,
almost all signaling domains of the activating Ly49 receptors
of mouse and rat derive from a single ancestral activating sig-
nal domain. Reconstruction of ancestral sequences for the
four nodes indicated by arrows in Fig. 6 A supports a model
in which this ancestral activating signaling domain was pro-
duced by mutation and functional switch of a rodent inhibi-
tory signaling domain. We estimate that this functional
switch occurred 18.5–31 MYA (Table II), indicating it was
rodent specific, because the earliest divergence within rodents
occurred  75 MYA (37, 38). The activating Ly49 could also
be specific to Murinae, because they separated from their
closest relatives, the Cricetidae and the Gerbillidae,  31 and
 34 MYA (38), respectively, a time at the upper range of
our estimate for the functional switch (Table II).
An independent and more recent functional switch must
be proposed to account for the formation of the activating rat
Ly49s3 receptor. The clustering of the Ly49s3 signaling do-
main with four other rat Ly49 sequences that have activating
(charged residue in the TM) and inhibitory (ITIM in CYT)
motifs points to this evolution having first involved the acquisi-
tion of a charged residue in the transmembrane region fol-
lowed by loss of ITIM from the cytoplasmic tail. This model is
also supported by reconstruction of the ancestral signaling do-
main shared by Ly49s3 and its close relatives. That these are all
rat sequences raises the possibility of a rat-specific emergence.
However, an analysis of the time of emergence of this receptor
indicates a range of  3.5 to 15.5 MYA (Table II), leaving
open the alternative possibility that receptor emergence pre-
ceded the mouse and rat separation,  13–21 MYA (37).
The tight clustering observed for the signaling domains
of most rat and mouse activating Ly49 receptors (Fig. 6 A)
Figure 5. Signaling adaptor molecules DAP12 and FCER1G existed 
long before the emergence of activating primate KIR and rodent 
Ly49 receptors. Phylogenetic trees (A) of the DAP12 family and (B) of the 
FCER1G family. Tree construction, evaluation, and statistical tests were as 
in Fig. 3; representative NJ trees are shown. For simplification, some 
groups of sequences were collapsed; the number of the sequences in such 
groups is indicated.JEM VOL. 201, April 18, 2005 1327
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does not extend to trees made from the sequences of the ex-
tracellular stalk (not shown) or lectinlike domain (Fig. 6 B).
The overall pattern is very similar to that seen for the activat-
ing KIR (Figs. 1 and 3) and shows that new activating Ly49
receptors have been formed principally through recombina-
tion that replaces the signaling domain of an inhibitory re-
ceptor with the signaling domain of an existing activating re-
ceptor. In this and all other aspects of their evolution, the
parallels between the activating receptors of the rodent Ly49
family and the primate KIR family are striking.
DISCUSSION
Before the evolution of adaptive immunity, lymphocyte-like
cells probably existed and, like modern NK cells, used recep-
tors encoded by nonrearranging genes (39). Also, the diverse
functions of MHC class I–like molecules point to their exist-
ence before adaptive immunity. It is therefore plausible that
lymphocytes of innate immunity have been regulated by class
I–like receptors for more than 500 million years. Although
this general function was conserved, its manifestations in dif-
ferent mammalian species are notably divergent. The func-
tionally analogous but structurally dissimilar KIR and Ly49
receptors seem to be extreme in this regard: both the recep-
tors and their MHC class I ligands are highly polymorphic
and rapidly evolving (36, 40). Despite the differences, many
aspects of the biology of the primate KIR and rodent Ly49
families are remarkably similar, including a membership of
both inhibitory and activating receptors (6, 7).
Here we demonstrate that the inhibitory KIR and Ly49
receptors were ancestral and that the activating receptors are
derived from them. Thus, all modern primate KIR derive
from a common ancestral primate KIR that had inhibitory
function. Of more recent origin are the activating STK,
which are specific to the hominoids and have notably ex-
Figure 6. Activating Ly49 evolved by functional shift of inhibitory 
Ly49 and subsequent expansion through recombination. Phylogenetic 
trees were constructed from nucleotide sequences corresponding to the 
different domains of Ly49 receptors: (A) the cytoplasmic domain and 
transmembrane region (CYT/TM)–signaling domain; the stalk (not shown); 
and (B) the lectinlike domain. Ly49 with activating function or potential 
are boxed (including pseudogenes that would encode activating receptors 
in the absence of frameshifts). The predicted activating horse Ly49C (67) is 
also boxed, although the position of its charged residue in the TM differs 
from that of known activating Ly49. Tree construction, evaluation, and 
statistical tests were as in Fig. 3; representative NJ trees are shown. 
Reconstruction of the ancestral sequences was performed for four nodes 
of the signaling domain tree (arrows in A), using marginal reconstruction 
and Bayesian analysis. The presence of an ITIM in the CYT and a charged 
residue in the TM is indicated for each of these nodes. For simplification, 
the mouse sequences lack species abbreviations (strains are indicated in 
parentheses).   indicates a pseudogene or a sequence with an abnormal 
frame. Predicted rat sequences are indicated by a number in parenthesis. 
Bta, Bos Taurus; Car, Carnivora; Cet, Cetartiodactyla; Cfa, Canis familiaris; 
Eca, Equus caballus; Fca, Felis catus; Hsa, Homo sapiens; Per, Perissodactyla; 
Pha, Papio hamadryas; Popy, Pongo pygmaeus; Rno, Rattus norvegicus; 
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panded in the human species to give the diversity of group B
KIR haplotypes. The STK share a common ancestor that
was an inhibitory KIR. Reconstructing such evolution of an
activating KIR from an inhibitory KIR shows that it oc-
curred only once in hominoids and involved as few as five
to seven nucleotide changes. These changes introduced a
charged residue into the transmembrane domain and altered
both the length and the sequence of the cytoplasmic tail to
eliminate the ITIMs. By this process of functional shift, the
first hominoid STK emerged 13.5–18 MYA. Subsequently,
additional STK were formed through the action of two
other evolutionary mechanisms: recombination, which re-
placed the signaling domain of inhibitory receptors with the
activating domain, and, to a lesser extent, duplication of
STK genes with subsequent divergence of the daughter
genes (Fig. 7 A). The activating Ly49 genes evolved by sim-
ilar processes from inhibitory Ly49 genes.
The signaling domains of the activating KIR in rhesus
monkey and cattle are unrelated to those of the hominoids,
indicating that this form of signaling domain has evolved in-
dependently in different species at different times. The for-
mation of activating receptors from inhibitory receptors is
seen to be a recurrent process. This recurrence is no coin-
cidence, because of the competitive advantage of new vari-
ant receptors that can engage an adaptor molecule (e.g.,
DAP12), which is part of an existing pathway of activating
Figure 7. Model for the emergence and loss of activating KIR and 
Ly49. (A) An inferred history for the origin and spread of hominoid STK, 
rhesus monkey KIR3DH, and activating Ly49 in rodents is shown. Boxes 
represent the different protein domains. For the signaling domain, charged 
residues and ITIMs are represented by the corresponding amino acid and by 
a filled square, respectively. When recombinant structures are present, the 
lineage of the recombinant domains is indicated by a roman letter below 
the domain. (B) Two-stage model for the emergence and loss of activating 
KIR and Ly49. The creation of an activating receptor is followed by a rapid 
increase in frequency caused by the beneficial effects (resistance to 
pathogens, increase in reproductive success). When the selective advan-
tage of the activating receptor disappears, its negative effects (disabilities 
caused by autoimmunity or a detrimentally high birthrate) lead to decreasing 
frequency and eventual gene loss. Alternatively, or in parallel to this decrease 
in frequency, substitutions that decrease or eliminate the function of the 
activating receptor can occur and be selected.JEM VOL. 201, April 18, 2005 1329
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signal transduction. Such activating receptors therefore will
tend to be selected.
Although the signaling adaptors have been conserved for
more than 400 million years, and both KIR and Ly49 have
existed for at least 100 million years, none of the modern-
day activating KIR or Ly49 are older than  18 and  31
million years, respectively. The recurrent creation of activat-
ing receptors and the absence of ancient lineages of activat-
ing receptors indicates that activating receptors are short
lived: they are periodically made, lost, and reinvented, rather
than being preserved by strong, persistent selection. Further
evidence for this dynamic comes from the distribution of
STK in human populations. Overall, the STK have lower
frequencies than the inhibitory KIR (41–43), and in some
populations (e.g., the Japanese) the frequencies of STK and
group B KIR haplotypes are very low (43). None of the
STK genes is fixed, and because a common allele of
KIR2DS4—the single STK of the group A haplotypes—is
probably nonfunctional, many millions of healthy people
have no STK at all. These observations all point to natural
selection having the capacity to select for or against activat-
ing KIR and Ly49, depending on circumstance.
The functions of inhibitory KIR are better understood
than those of activating KIR. They are MHC class I receptors
that help NK cells be tolerant of healthy autologous cells but
reactive toward cells having perturbed MHC class I expres-
sion (44). In humans, HLA-C is the major inhibitory ligand;
all HLA-C allotypes engage inhibitory KIR2DL, and most
KIR haplotypes and genotypes encode inhibitory KIR spe-
cific for two broad groups of HLA-C ligand, C1 and C2 (45).
By contrast, a minority of HLA-A and -B allotypes are inhib-
itory ligands, and a significant proportion of KIR haplotypes
do not encode a functional inhibitory HLA-B receptor.
The interaction of HLA-C1 with its cognate receptors
KIR2DL2 and -3 is weaker than that for HLA-C2 and
KIR2DL1 (15, 46). Such polymorphism, combined with in-
dependent segregation of KIR and HLA-C, means that indi-
viduals differ qualitatively and quantitatively in their NK cell
regulation by HLA-C. Consequently, individuals having
only the weaker inhibition mediated by C1 binding to
KIR2DL3 are more likely to resolve acute hepatitis C virus
infections (47), presumably because their NK cells are more
readily activated. Other correlative studies show that weaker
inhibitory KIR–HLA-C interactions and/or the presence of
activating STK is associated with slower progression of HIV
infections to AIDS (19) and reduced risk of preeclampsia in
pregnancy (48). Conversely, group B KIR haplotypes, with
their STK, are also associated with a increased likelihood of
autoimmune diseases such as psoriasis (49, 50), psoriatic ar-
thritis (20, 51), type I diabetes (22), scleroderma (52), and
vascular complications of rheumatoid arthritis (21).
These clinical correlations indicate that the potential ad-
vantages of STK are improvement in the response to infec-
tion and increased reproductive success; they also indicate
that their potential disadvantage is increased disability result-
ing from autoimmunity. Although autoimmunity has often
been dismissed as a factor in natural selection, because it usu-
ally affects people past reproductive age, such conjecture ig-
nores the important contributions that healthy older rela-
tives, notably grandparents, could have made to raising
children. During episodes of epidemic viral infection, geno-
types containing STK are more likely to be advantageous
and selected, whereas in periods when infections are less
pressing, genotypes without STK could gain the competitive
advantage. The short life of activating KIR and Ly49 can
therefore be explained by a two-stage model: a first stage, in
which a low-frequency activating receptor is rapidly driven
to high frequency because of its beneficial effect, is followed
by a second stage during which the benefit is outweighed by
the detriment, leading to decreasing frequency and eventual
loss of the activating receptor gene (Fig. 7 B).
Although the clinical correlations point to their influence,
the manner by which the STK exert their effects is uncertain,
because their ligands have yet to be defined. Although the
ligand-binding domains of KIR2DS1 and KIR2DL1 are sim-
ilar, as are those of KIR2DS2 and KIR2DL2/3, the STK
have little, if any, affinity for HLA-C. Indeed, mutational and
structural analysis shows that KIR2DS1 and KIR2DS2 have
each acquired a single–amino acid substitution that prevents
the binding of C2 and C1, respectively (15–18). One possi-
bility is that KIR2DS binding is much more dependent on
the peptide bound by HLA-C than is KIR2DL binding, as
reported for KIR3DL2 (53). Alternatively, receptors that
were originally selected by infection as activating HLA-C re-
ceptors, may have subsequently become attenuated or inacti-
vated when the disease was no longer a threat. Support for
this alternative is found with the Ly49 family, because several
Ly49 pseudogenes would encode activating receptors in the
absence of frameshifts (see Fig. 6 A for example).
The hominoid STK emerged at a time,  13.5–18 MYA,
soon after the previously isolated continents of Africa and
Eurasia were connected,  18 MYA (54). This event facili-
tated the migration of many African mammals to Eurasia, in-
cluding hominoids, for which fossils unearthed in Europe
date to as early as 16–17 MYA (55). Several authors have
proposed that the hominoids who migrated to Eurasia even-
tually gave rise to humans and the other surviving hominoid
species (55). In that circumstance, the period starting  18
MYA would have been one of environmental upheaval for
hominoid ancestors. The resulting stress and pressure on
their immune systems might well have contributed to the se-
lection of a new variety of activating KIR. Through recom-
bination and gene duplication, this ancestral STK would
eventually lead to the expanded family of STK present in
modern hominoids. The expansion also witnessed striking
parallels in evolution (e.g., the independent formation of ac-
tivating KIR with three Ig domains in bonobos, orangutans,
and humans). This parallelism emphasizes the importance of
natural selection, not only in the emergence of activating
KIR, but also in their expansion and diversification.EMERGENCE OF ACTIVATING KIR AND LY49 | Abi-Rached and Parham 1330
MATERIALS AND METHODS
Datasets and alignments. Our KIR dataset included all known KIR loci
and sequences having  1% divergence. The signaling domain analyses were
performed using the sequences from exon 7–9. Sequences with the longest
3  untranslated regions were chosen. Gg-KIR2DL6,  Gg-KIR2DLc,  Pt-
KIR3DL6, Pp-KIR3DL4, and Pt-KIRC1 were not used for analysis of the
signaling domain, because they are recombinants that give divergent phylo-
genetic signals for the TM and CYT (24). KIR3DS1 and KIR3DL1 were
also found to have divergent signals within the CYT domain (unpublished
data), and part of the 3  untranslated region sequence was removed to avoid
bias. Bta-KIR2DS1 was too short for analysis of the TM and CYT domains.
The 3  ends of the nonprimate KIR sequences were trimmed to conserve
only the well-aligned parts.
To obtain a DAP12 dataset, BLAST (56) searches were made of National
Center for Biotechnology Information’s nonredundant and expressed se-
quence tags databases. This search also revealed DAP10, CD3 / , and CD3 
sequences, which we included in the analysis. The FCERIG dataset was ob-
tained similarly to the DAP12 dataset but also includes CD3  sequences.
An Ly49 dataset was assembled following BLAST searches. Full-length
rat sequences predicted based on genomic DNA were also included (57).
Groups of sequences with  1% divergence were represented by one se-
quence. Alignment columns containing single sequences were discarded, as
were the insertions found in several sequences that did not align (divergent
splice variants).
KIR and Ly49 nucleotide sequences were aligned using MAFFT (58)
and were corrected manually; DAP12 and FCERIG amino acid alignments
were generated using T-coffee (59).
Phylogenetic analyses. Before the analysis of each dataset, we checked
for composition bias using a  2 test (    0.05). For nucleotide sequence
analyses, we selected the model of DNA substitution using the Akaike in-
formation criterion as implemented in Modeltest 3.06 (60). Neighbor-join-
ing (NJ) analyses were performed with MEGA3 (61) using 1,000 replicates,
pairwise comparisons, midpoint rooting, and, in all but one case, the
Tamura-Nei method. Because of sequence composition bias with three se-
quences in Fig. 1 A (mouse and rat KIR3DL1: P   0.001; horse
KIR3DL001: P   0.05), we used the LogDet method. To define groups,
we performed the interior branch test (62). For Bayesian analyses we used
MrBayes3b4 (63) and conducted three independent runs for each dataset
(see supplemental Materials and methods, available at http://www.jem.
org/cgi/content/full/jem.20042558/DC1). The three topologies obtained
were compared statistically using the Shimodaira-Hasegawa test of alterna-
tive phylogenetic hypotheses, as implemented in PAUP*4.0b10 (Sinauer),
with resampling estimated log-likelihood optimization and 10,000 boot-
strap replicates. This comparison was made with the maximum likelihood
model defined by Modeltest. For all the analyses presented, the test failed to
reject any of the alternative tree topologies (    0.05). PAUP*4.0b10 and
the tree bisection-reconnection branch swapping algorithm were used for
maximum likelihood and parsimony analyses, with 500 replicates and
Modeltest parameters for the former and 1,000 replicates and a heuristic
search for the latter.
The analyses of amino acid sequences were performed similarly to the
analyses of the nucleotide sequences with the following differences: NJ
analyses were performed using a Poisson correction; the Bayesian analyses
were conducted using a BLOSUM matrix and gamma distances; and the re-
sulting tree topologies were statistically compared using the Templeton test
with a parsimony model (    0.05).
In the analysis of each dataset, the tree topologies obtained with the
different methods were compared using the Shimodaira-Hasegawa test or
the Templeton test as described previously. In all analyses but one, the test
failed to reject any topology. The NJ tree presented in Fig. 6 A was less
likely than the other two trees (Shimodaira-Hasegawa test, P   0.05). Be-
cause the difference was not significant at a 1% level, and because the nodes
responsible affected only terminal branches, which were not discussed in the
analysis, the NJ tree was kept.
Ancestral sequence reconstruction. Ancestral sequences were recon-
structed using the marginal reconstruction approach of PAML (64) and
Bayesian analysis using MrBayes2.01. Marginal reconstruction used the
model of DNA substitution defined by Modeltest. Bayesian analyses were as
described previously, except that nodes for which ancestral sequence recon-
struction was sought were constrained. More than five runs were per-
formed, and a consensus was generated.
Estimation of divergence time. Mean, standard deviation, and 95%
confidence interval values for divergence times were estimated using the
Bayesian relaxed molecular clock approach with the Multidistribute pro-
gram package (reference 65 and see supplemental Material and methods).
For the KIR dataset, the two topologies of Fig. 2 were used, the mean of
the prior distribution of the root of the ingroup tree was set to 27   3 MYA
(hominoid–Old World monkey separation), and two nodes in the lineage II
and STK groups were constraints between 10 and 18 MYA (separation of
orangutans from humans and African apes). For the Mm-KIR3DH dataset, the
tree topology of model 1 in Fig. 2 was used, and the root of the ingroup tree
was set to 27   3 MYA (hominoid–Old World monkey separation). For the
Ly49 dataset, a modified version of the tree topology obtained in the Bayesian
analysis performed for Fig. 6 A was used; the root of the ingroup tree was set
to 87.5   3.5 MYA (primate–rodent separation), and three internal calibra-
tions corresponding to the divergence between mouse and rat (13–21 MYA)
were used (see online supplemental Material and methods).
Analysis of functional constraints. Sequences containing insertions or
deletions that changed the reading frame size were removed, as were se-
quences having premature stop codons. The final stop codons were re-
moved, as were the positions with gaps. The number of dS and dN were
estimated using MEGA3 with the modified Nei-Gojobori method (p-dis-
tance). The transition/transversion ratio was estimated using Treepuzzle
(66). The SEs were estimated by the bootstrap method (10,000 replicates).
The statistical significance of the dN/dS ratios comparing to the neutrality
hypothesis was assessed through a two-tailed Z-test.
Online supplemental material. Detailed methods for the Bayesian phy-
logenetic analyses, the divergence time analyses, the analysis presented in
Fig. 3 A, and the accession numbers for the sequences used are described in
supplemental Material and methods. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20042558/DC1.
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